FOLH1 and neoplasm: PSMA-TV significantly stratified patients at high versus low-risk for biochemical recurrence (p = 0.05), and PSMA-TLU showed a significant discrimination for patients at high versus low-risk for loco-regional tumor recurrence (p = 0.016).